Sweden· SE-20240923000075
Azelainsyra Evolan 150 mg/g Gel
A azelainsyre product containing azelaic acid, registered in Sweden by Evolan Pharma AB.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Azelaic Acid
- Manufacturer
- Evolan Pharma AB
- Country
- Sweden (SE)
- ATC code
- Azelainsyre
- ATC class
- Azelainsyre
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20240923000075
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Azelaic acid in 13 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- United Statesazelaic acidGlenmark Pharmaceuticals Inc., USA
- PolandSkinorenLEO Pharma A/S
- SpainFINACEA 150 mg/g GELLeo Pharma A/S
- FinlandSkinorenLeo Pharma A/S
- NorwayFinaceaLEO PHARMA A/S (Danmark)
- United KingdomFinacea 15% gelLEO Pharma
- FranceFINACEA 15 %, gelLEO PHARMA A/S (DANEMARK)
- CzechiaSKINORENLEO Pharma A/S, Ballerup
Authorised across Europe · EMA
The same active substance is authorised in 26 EEA countries. Names it is sold under:
- Austria · Finacea, Skinoren
- Belgium · Skinoren
- Bulgaria · Скинорен, Финацеа
- Cyprus · Skinoren
- Czechia · Skinoren
- Germany · Skinoren
- Denmark · Finacea, Skinoren
- Estonia · Finacea, Skinoren
- Spain · Finacea, Zeliderm
- Finland · Skinoren
- France · Finacea, Skinoren
- United Kingdom (Northern Ireland) · Finacea, Skinoren
- Greece · Arbonid, Azelderm
- Croatia · Skinoren
- Hungary · Finacea, Skinoren
- Ireland · Skinoren
- Italy · Finacea, Skinoren
- Lithuania · Finacea, Skinoren
- Luxembourg · Skinoren
- Latvia · Finacea, Skinoren
- Norway · Finacea, Skinoren
- Poland · Skinoren, Skinoren Rosacea
- Portugal · Skinoren
- Romania · Skinoren
- Slovenia · Skinoren
- Slovakia · Finacea, Skinoren
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/1cb6014f-903b-406d-a0e5-dcc36c5ddc8e GET /v1/drugs/1cb6014f-903b-406d-a0e5-dcc36c5ddc8e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"SmPC",
"sRMP",
"PL",
"PAR"
],
"se_npl_id": "20240923000075",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20240923000075",
"product_doc_link": "https://docetp.mpa.se/LMF/Azelainsyra%20Evolan%20150%20mg%20per%20g%20gel%20SmPC_09001bee8503079c.pdf"
}See everything about azelaic acid.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.